Skip to content
healthcare.dev

CILOSTAZOL

NDC 84386-002, CILOSTAZOL, tablet, from Aurobindo Pharma Limited.

Product NDC
84386-002
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077019
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84386-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CILOSTAZOL50 mg/1

Pharmacologic classes

Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 3 Inhibitors [MoA]

Package NDCNDC-11Package
84386-002-608438600026060 TABLET in 1 BOTTLE (84386-002-60)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7c841eed-a98f-43c3-baaf-bf5502207a69

Use it

Look up 84386-002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84386-002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84386-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.